Professor Wang Shuo: Cerebrovascular Neurosurgery Expert in Beijing

Professor Wang Shuo: Cerebrovascular Neurosurgery Expert in Beijing

Professor Wang Shuo: Brain Aneurysm and Vascular Malformation Specialist

Professor Wang Shuo is a senior neurosurgeon, professor, doctoral supervisor, and director of the Neurosurgery Center at Beijing Tiantan Hospital. His clinical and academic work focuses on brain aneurysms, arteriovenous malformations, moyamoya disease, intracerebral hemorrhage, intracranial tumors, microsurgery, minimally invasive neurosurgery, and hybrid cerebrovascular procedures.

Clinical and Academic Focus

  • ruptured and unruptured brain aneurysms;
  • brain arteriovenous malformations;
  • moyamoya disease;
  • spontaneous intracerebral hemorrhage;
  • complex cerebrovascular microsurgery;
  • hybrid open and endovascular treatment;
  • selected intracranial tumors;
  • minimally invasive neurosurgical techniques; and
  • second opinions before high-risk brain surgery.

Brain Aneurysms

A brain aneurysm is a weakened area of an artery that can enlarge or rupture. Rupture causes subarachnoid hemorrhage, a life-threatening emergency that often presents with a sudden severe headache, vomiting, neck stiffness, collapse, or neurological deficit.

Treatment options include microsurgical clipping, endovascular coiling, flow diversion, intrasaccular devices, or observation. The choice depends on rupture status, aneurysm size and shape, location, branch vessels, age, general health, and the experience of the treating center.

Brain Arteriovenous Malformations

A brain arteriovenous malformation, or AVM, is an abnormal connection between arteries and veins. It may present with bleeding, seizures, headache, or neurological symptoms, although some are discovered incidentally.

Treatment can involve microsurgery, embolization, stereotactic radiosurgery, observation, or a staged combination. The plan should balance lifetime hemorrhage risk against the risks of intervention.

Moyamoya Disease

Moyamoya disease causes progressive narrowing of major arteries at the base of the brain and the development of fragile collateral vessels. It can lead to ischemic stroke, transient attacks, hemorrhage, headache, or cognitive problems.

Surgical revascularization may improve blood flow in selected patients. Direct, indirect, or combined bypass is chosen according to age, symptoms, vascular anatomy, perfusion, and surgical assessment.

Hybrid Cerebrovascular Surgery

A hybrid operating environment combines open microsurgery with catheter angiography and endovascular techniques. It can allow immediate imaging confirmation, staged treatment during one anesthetic, or rapid management of a complex vascular problem.

Not every patient requires a hybrid procedure. The treatment should be driven by lesion anatomy and safety rather than technology alone.

Intracerebral Hemorrhage

Spontaneous intracerebral hemorrhage causes bleeding directly into brain tissue. Management may include blood-pressure control, reversal of anticoagulation, intensive care, minimally invasive evacuation, open surgery, treatment of the underlying vascular lesion, and rehabilitation.

Professor Wang led the E-START randomized study evaluating early aspirin use after surgery for spontaneous intracerebral hemorrhage. Medication decisions after bleeding must remain individualized and should never be changed without the treating stroke team.

Minimally Invasive Neurosurgery

Keyhole approaches, endoscopy, navigation, intraoperative imaging, and advanced monitoring can reduce tissue disruption in selected cases. A smaller opening does not necessarily mean a lower-risk operation, especially near critical vessels and functional brain areas.

Who May Consider a Consultation?

  • patients with a ruptured or complex unruptured brain aneurysm;
  • patients with a brain AVM or other vascular malformation;
  • patients with moyamoya disease and ischemic or hemorrhagic symptoms;
  • patients comparing clipping, endovascular treatment, and observation;
  • patients with recurrent or residual disease after previous treatment;
  • patients with spontaneous brain hemorrhage requiring surgical review;
  • patients advised to undergo high-risk cerebrovascular surgery; or
  • patients seeking a second opinion on hybrid treatment.

Medical Records to Prepare

  • a precise symptom and treatment timeline;
  • brain CT and MRI in original DICOM format;
  • CTA, MRA, and catheter angiography with full image sequences;
  • perfusion imaging and cerebrovascular-reserve studies when available;
  • previous embolization, clipping, bypass, radiation, and operative records;
  • intensive-care and brain-hemorrhage records;
  • neurological, seizure, cognitive, and rehabilitation assessments;
  • blood pressure, coagulation, kidney function, and vascular-risk results;
  • a complete medication list, especially antiplatelet and anticoagulant medicines; and
  • a clear list of treatment goals and questions.

Planning an International Consultation

A sudden severe headache, new weakness, seizure, confusion, loss of consciousness, or other acute stroke symptom requires immediate local emergency care. International travel must not delay treatment.

Stable patients should confirm whether original angiography and imaging can be reviewed. Remote medical-record review requires physician authorization. Final procedure selection and eligibility usually require in-person neurological and neurosurgical assessment.

How CMCS Can Assist

CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating cerebrovascular records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.

Access to Professor Wang, remote review, surgery, endovascular therapy, or a hybrid procedure is subject to doctor and hospital approval. CMCS does not guarantee appointments, procedure eligibility, or clinical outcomes.

Important Note

Doctor titles, clinical roles, devices, procedures, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace assessment by a qualified cerebrovascular neurosurgery team.

0件のコメント

コメントを残す